AzTrials
AzTrials

Intervention GroupNCT07489170

Innovative Web-based Service Platform Called Adult Wellbeing CheckUp (AWC) to Assess Older Adults Wellbeing, Obtain Evidence-based Recommendations, and Receive Support to Take Action.

A study testing Adult Wellbeing CheckUp (AWC) and General Healthy Aging Information in people with Intervention Group and Control Group, run by BellAge Inc. at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn whether a web-based program called the Adult Wellbeing CheckUp (AWC) can help older adults improve their wellbeing and take actions to support healthy aging. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Intervention Group, Control Group
What is being tested?
Adult Wellbeing CheckUp (AWC) and General Healthy Aging Information
Could I receive a placebo?
No, everyone receives an active treatment
How many people
496 participants
Where
1 siteUnited States
Study dates
6 Apr 2026to 6 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • older adults aged 60 years or older,
  • able to speak and write in English,
  • a PHQ-2 depression screening score of less than 3,
  • has ability to access the internet,
  • can demonstrate literacy using online platforms, and
  • has access to an active email account that they can use to receive study-related communications.

Who cannot join

  • less than 60 years of age
  • not able to speak and write in English
  • a PHQ-2 depression screening score of 3 or greater
  • not able to access the internet, and
  • not able to demonstrate literacy using online platforms

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Diana Yin, M.P.P., M.B.A. contact

(917) 863-2923

diana.yin@betterage.net

United States1 site
  • BellAge Inc.dba BetterAge

    Sunnyside, New York, 11104

    Diana Yin, M.P.P., M.B.A., (917) 863-2923, diana.yin@betterage.net

    James Firman, MBA, Ed.D.

Other trials in United States

About this study

Official title: Adult Wellbeing CheckUp (AWC)

The goal of this clinical trial is to learn whether a web-based program called the Adult Wellbeing CheckUp (AWC) can help older adults improve their wellbeing and take actions to support healthy aging. The study will include adults aged 60 years and older, including both older adults and people who care for someone living with Alzheimer's disease or related dementias.

The main questions this study aims to answer are:

Read more
  1. Does using the Adult Wellbeing CheckUp increase participants' ability to manage their health and wellbeing, measured by the Patient Activation Measure (PAM-13)?
  2. Do participants who use the Adult Wellbeing CheckUp take more actions to improve their wellbeing compared with those who do not use the program?

Researchers will compare participants who use the AWC platform with participants who receive general healthy aging information to see whether the AWC program leads to greater improvements in wellbeing and health engagement.

The AWC platform is an online tool that helps older adults review their wellbeing across several areas of life, such as physical health, mental health, social connections, and daily habits. After completing an online assessment, the platform provides personal action plans and specific recommendations to help participants improve areas where their wellbeing scores are low.

About 496 participants aged 60 and older will take part in this study. This group will include both older adults and care partners for people living with Alzheimer's disease or related dementias. Participants will take part in the study for about 24 weeks (6 months).

Participants will be randomly assigned (by chance) to one of two groups:

  1. Intervention group: Participants will create an account and use the Adult Wellbeing CheckUp platform for 24 weeks. They will complete a wellbeing assessment and receive personal action plans and specific recommendations. They will also receive weekly encouragement messages and personalized check-ins by email or text.
  2. Comparison group: Participants will complete the same baseline assessment but will not have access to the AWC platform during the study. Instead, they will receive weekly general healthy aging information by email.

All participants will complete surveys at the start of the study, at 12 weeks, and at 24 weeks. These surveys will measure health engagement, wellbeing, and actions taken to improve wellbeing. After the study ends, participants in the comparison group may be offered access to the platform in a future time.

Researchers will use the results of this study to learn whether the Adult Wellbeing CheckUp can help older adults take meaningful steps to improve their health and wellbeing.

Being tested
Adult Wellbeing CheckUp (AWC), General Healthy Aging Information
Keywords
Healthy aging, Caregiver wellbeing, Patient activation, Digital health intervention, Older adults
Medical subject headings
Patient Participation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Adult Wellbeing CheckUp (AWC)Behavioural

    The Adult Wellbeing CheckUp (AWC) is a web-based wellbeing assessment and recommendation platform designed for older adults and care partners. Participants complete an online assessment of multiple wellbeing domains. The platform uses a rules-based algorithm to generate evidence-based guidance and actionable plans for domains with low scores or areas participants choose to improve. Participants in the intervention arm receive ongoing encouragement messages and check-ins via email or text over the 24-week study period.

  • General Healthy Aging InformationBehavioural

    Participants receive weekly non-personalized informational messages about general healthy aging topics delivered by email during the 24-week study period. These messages provide general education but do not include personal recommendations, interactive features, or access to the Adult Wellbeing CheckUp platform.

Study groups in NCT07489170
Study groupRoleWhat they receive
Adult Wellbeing CheckUp (AWC) Intervention GroupExperimentalParticipants in this arm will use the Adult Wellbeing CheckUp (AWC), a web-based wellbeing assessment and recommendation platform, for 24 weeks. After completing the baseline assessment, participants will answer domain-specific follow-up questions for wellbeing areas with low scores or areas they want to improve. Based on these responses, the platform will generate evidence-based recommendations and actionable plans. Participants will also receive ongoing encouragement messages and check-ins by email or text during the 24-week study period.
Receives: Behavioral: Adult Wellbeing CheckUp (AWC)
General Healthy Aging Information Control GroupActive comparatorParticipants in this arm will complete the same baseline assessment as the intervention group but will not receive access to the Adult Wellbeing CheckUp platform, personal action plans or recommendations, or digital support during the 24-week study period. Instead, they will receive weekly non-personalized general healthy aging informational messages by email.
Receives: Behavioral: General Healthy Aging Information

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Patient Activation Measure (PAM-13) Score

    Patient activation measured using the 13-item Patient Activation Measure (PAM-13), a validated survey that assesses participants' knowledge, skills, and confidence for managing their health and wellbeing. Scores range from 0 to 100, with higher scores indicating greater activation. The primary analysis will compare change in PAM-13 scores between intervention and control groups.

    Measured: Baseline, Week 12, and Week 24

Secondary outcomes (12)
  1. Change in Self-Reported Actions Taken

    Participant-reported actions taken to improve wellbeing in prioritized domains based on recommendations provided during the study. Responses are used to assess follow-through on recommended wellbeing actions.

    Measured: Baseline and Week 24

  2. Change in Adult Wellbeing Assessment Score

    Overall wellbeing measured using the Adult Wellbeing Assessment, a 13-item self-report questionnaire designed for older adults. The measure assesses multiple domains of wellbeing, including physical health, mental and emotional wellbeing, social connection, sense of purpose, and daily functioning. Responses are scored to produce an overall wellbeing score, with higher scores indicating better overall wellbeing.

    Measured: Baseline and Week 24

  3. Change in Patient Health Questionnaire-4 (PHQ-4) Score

    Mental health symptoms measured using the Patient Health Questionnaire-4 (PHQ-4), a validated 4-item screening tool assessing anxiety and depression symptoms. Scores range from 0 to 12, with higher scores indicating greater symptom severity.

    Measured: Baseline and Week 24

  4. Change in Rapid Assessment of Physical Activity (RAPA) Score

    Physical activity level measured using the Rapid Assessment of Physical Activity (RAPA). Aerobic activity (RAPA-1) is scored based on the highest numbered activity level endorsed (1-7), classifying participants from sedentary to active. Strength and flexibility activities (RAPA-2) are recorded separately and categorized as none (0), strength only (1), flexibility only (2), or both strength and flexibility activities (3).

    Measured: Baseline and Week 24

  5. Change in UCLA Loneliness Scale-3 Score

    Emotional loneliness measured using the UCLA Loneliness Scale-3, a validated 3-item self-report scale assessing perceived loneliness and social isolation. Scores range from 3 to 9, with higher scores indicating greater loneliness.

    Measured: Baseline and Week 24

  6. Change in Lubben Social Network Scale (LSNS-6) Score

    Social isolation measured using the Lubben Social Network Scale (LSNS-6), a validated 6-item measure assessing perceived social support from family and friends. Scores range from 0 to 30, with higher scores indicating larger and more supportive social networks.

    Measured: Baseline and Week 24

  7. Change in Duke Sense of Belonging Short Form Score

    Sense of belonging and social connectedness measured using two items adapted from the Duke Social Support/Sense of Belonging questionnaire assessing frequency of contact and time spent with friends or family. The first item assesses frequency of contact with friends or family (in person, by phone, or by video) and is scored on a 5-point scale from 1 (rarely or never) to 5 (daily). The second item assesses the number of times participants spend time with someone who does not live with them in a typical week and is scored on a 4-point scale from 1 (none) to 4 (five or more times). Item scores are summed to produce a total score ranging from 2 to 9, with higher scores indicating greater social connectedness and sense of belonging.

    Measured: Baseline and Week 24

  8. Change in PROMIS Sleep Disturbance Short Form Score

    Sleep disturbance measured using the PROMIS Sleep Disturbance Short Form (8a), an 8-item validated self-report questionnaire assessing perceived sleep quality, sleep depth, and difficulty falling or staying asleep over the past seven days. Each item is rated on a 5-point response scale. Responses are summed to produce a raw score ranging from 8 to 40. Higher T-scores indicate greater sleep disturbance.

    Measured: Baseline and Week 24

  9. Change in Topic-Level Impact Ratings

    Change in perceived impact of actions taken within prioritized wellbeing domains measured using a single-item question. Participants rate the impact of actions taken in specific domains using a numeric rating scale from 0 to 10, where 0 indicates no impact and 10 indicates very high positive impact on wellbeing. Higher scores indicate greater perceived positive impact of actions taken within the selected wellbeing domain.

    Measured: Week 12 and Week 24

  10. Change in Global Impact of Actions Score

    Change in perceived overall impact of actions taken on wellbeing measured using a single-item question. Participants rate the overall impact of actions taken on their wellbeing using a numeric rating scale from 0 to 10, where 0 indicates no impact and 10 indicates very high positive impact on overall wellbeing. Higher scores indicate greater perceived overall benefit from actions taken.

    Measured: Week 12 and Week 24

  11. Reported Barriers to Taking Action

    Participant-reported barriers that may limit engagement with recommended wellbeing actions. Barriers are assessed using a survey question allowing participants to select one or more applicable options from a predefined list (e.g., time constraints, lack of resources, lack of motivation, or other challenges).

    Measured: Week 12 and Week 24

  12. Change in Zarit Burden Interview (ZBI-12) Score

    Change in caregiver burden among care partner participants measured using the 12-item Zarit Burden Interview (ZBI-12). Each item is rated on a 5-point Likert scale from 0 (never) to 4 (nearly always). Total scores range from 0 to 48, with higher scores indicating greater caregiver burden.

    Measured: Baseline and Week 24

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2026
  2. Study start6 Apr 2026 (estimated)
  3. Primary completion6 Apr 2027 (estimated)
  4. Study completion6 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
496 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07489170
Sponsor's protocol ID
4R44AG082602
Status last verified
Mar 2026
First submitted
19 Mar 2026
Last updated
23 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The research team has not yet determined whether individual participant data will be shared with external researchers. Any future sharing of de-identified data will be evaluated after study completion in accordance with participant consent, sponsor policies, and applicable privacy and data protection regulations.

Publications

  • Fauth E, Hess K, Piercy K, Norton M, Corcoran C, Rabins P, Lyketsos C, Tschanz J. Caregivers' relationship closeness with the person with dementia predicts both positive and negative outcomes for caregivers' physical health and psychological well-being. Aging Ment Health. 2012;16(6):699-711. doi: 10.1080/13607863.2012.678482.

    PubMed 22548375

Questions about this trial

What is this clinical trial studying?

A study testing Adult Wellbeing CheckUp (AWC) and General Healthy Aging Information in people with Intervention Group and Control Group, run by BellAge Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Diana Yin, M.P.P., M.B.A. ((917) 863-2923, diana.yin@betterage.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Patient Activation Measure (PAM-13) Score (time frame: Baseline, Week 12, and Week 24). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07489170, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in